Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
S-Adenosyl-L-methionine disulfate p-toluene-sulfonate is a stable salt form of S-Adenosyl-L-Methionine (SAMe), complexed with p-toluenesulfonic acid and bis(sulfates). SAMe is a naturally occurring compound involved in methyl group transfers and transsulfuration reactions in the body. As a supplement or drug, it has chemopreventive activity and is used for its potential benefits in treating depression, osteoarthritis, fibromyalgia, liver disorders including cholestatic liver diseases and alcoholic/non-alcoholic fatty liver disease. It may help restore glutathione concentrations in the liver and support detoxification processes. The precise mechanism of action involves acting as a methyl donor for various biochemical reactions essential for cellular function[1][2][6][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on s-adenosyl-l-methionine disulfate p-toluene-sulfonate.